210 related articles for article (PubMed ID: 7609052)
41. Efficient infection mediated by viral receptors incorporated into retroviral particles.
Balliet JW; Bates P
J Virol; 1998 Jan; 72(1):671-6. PubMed ID: 9420272
[TBL] [Abstract][Full Text] [Related]
42. Kinetic analysis of binding interaction between the subgroup A Rous sarcoma virus glycoprotein SU and its cognate receptor Tva: calcium is not required for ligand binding.
Yu X; Wang QY; Guo Y; Dolmer K; Young JA; Gettins PG; Rong L
J Virol; 2003 Jul; 77(13):7517-26. PubMed ID: 12805452
[TBL] [Abstract][Full Text] [Related]
43. Selection of an avian retrovirus mutant with extended receptor usage.
Taplitz RA; Coffin JM
J Virol; 1997 Oct; 71(10):7814-9. PubMed ID: 9311868
[TBL] [Abstract][Full Text] [Related]
44. Identification and characterization of a shared TNFR-related receptor for subgroup B, D, and E avian leukosis viruses reveal cysteine residues required specifically for subgroup E viral entry.
Adkins HB; Brojatsch J; Young JA
J Virol; 2000 Apr; 74(8):3572-78. PubMed ID: 10729132
[TBL] [Abstract][Full Text] [Related]
45. Mechanisms of avian retroviral host range extension.
Rainey GJ; Natonson A; Maxfield LF; Coffin JM
J Virol; 2003 Jun; 77(12):6709-19. PubMed ID: 12767991
[TBL] [Abstract][Full Text] [Related]
46. Importance of cysteines in the LDLR-related domain of the subgroup A avian leukosis and sarcoma virus receptor for viral entry.
Bélanger C; Zingler K; Young JA
J Virol; 1995 Feb; 69(2):1019-24. PubMed ID: 7815478
[TBL] [Abstract][Full Text] [Related]
47. A soluble form of a receptor for subgroup A avian leukosis and sarcoma viruses (ALSV-A) blocks infection and binds directly to ALSV-A.
Connolly L; Zingler K; Young JA
J Virol; 1994 Apr; 68(4):2760-4. PubMed ID: 8139053
[TBL] [Abstract][Full Text] [Related]
48. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
Delos SE; Burdick MJ; White JM
Virology; 2002 Mar; 294(2):354-63. PubMed ID: 12009877
[TBL] [Abstract][Full Text] [Related]
49. Identification and characterization of the viral interaction determinant of the subgroup A avian leukosis virus receptor.
Zingler K; Bélanger Ca; Peters R; Agard E; Young JA
J Virol; 1995 Jul; 69(7):4261-6. PubMed ID: 7769686
[TBL] [Abstract][Full Text] [Related]
50. Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating.
Barnard RJ; Narayan S; Dornadula G; Miller MD; Young JA
J Virol; 2004 Oct; 78(19):10433-41. PubMed ID: 15367609
[TBL] [Abstract][Full Text] [Related]
51. Intronic deletions of tva receptor gene decrease the susceptibility to infection by avian sarcoma and leukosis virus subgroup A.
Chen W; Liu Y; Li H; Chang S; Shu D; Zhang H; Chen F; Xie Q
Sci Rep; 2015 Apr; 5():9900. PubMed ID: 25873518
[TBL] [Abstract][Full Text] [Related]
52. A single-amino-acid substitution in the TvbS1 receptor results in decreased susceptibility to infection by avian sarcoma and leukosis virus subgroups B and D and resistance to infection by subgroup E in vitro and in vivo.
Reinisová M; Senigl F; Yin X; Plachy J; Geryk J; Elleder D; Svoboda J; Federspiel MJ; Hejnar J
J Virol; 2008 Mar; 82(5):2097-105. PubMed ID: 18094190
[TBL] [Abstract][Full Text] [Related]
53. Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.
Zhang XY; Kutner RH; Bialkowska A; Marino MP; Klimstra WB; Reiser J
Retrovirology; 2010 Jan; 7():3. PubMed ID: 20100344
[TBL] [Abstract][Full Text] [Related]
54. Intronic deletions that disrupt mRNA splicing of the tva receptor gene result in decreased susceptibility to infection by avian sarcoma and leukosis virus subgroup A.
Reinišová M; Plachý J; Trejbalová K; Šenigl F; Kučerová D; Geryk J; Svoboda J; Hejnar J
J Virol; 2012 Feb; 86(4):2021-30. PubMed ID: 22171251
[TBL] [Abstract][Full Text] [Related]
55. Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor.
Balliet JW; Berson J; D'Cruz CM; Huang J; Crane J; Gilbert JM; Bates P
J Virol; 1999 Apr; 73(4):3054-61. PubMed ID: 10074155
[TBL] [Abstract][Full Text] [Related]
56. Residues E53, L55, H59, and G70 of the cellular receptor protein Tva mediate cell binding and entry of the novel subgroup K avian leukosis virus.
Li X; Chen Y; Yu M; Wang S; Liu P; Meng L; Guo R; Feng X; Hu M; He T; Qi X; Li K; Gao L; Zhang Y; Liu C; Cui H; Wang X; Gao Y
J Biol Chem; 2023 Mar; 299(3):102962. PubMed ID: 36717079
[TBL] [Abstract][Full Text] [Related]
57. Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein.
Hernandez LD; White JM
J Virol; 1998 Apr; 72(4):3259-67. PubMed ID: 9525653
[TBL] [Abstract][Full Text] [Related]
58. Genetic Resistance to Avian Leukosis Viruses Induced by CRISPR/Cas9 Editing of Specific Receptor Genes in Chicken Cells.
Koslová A; Kučerová D; Reinišová M; Geryk J; Trefil P; Hejnar J
Viruses; 2018 Nov; 10(11):. PubMed ID: 30400152
[TBL] [Abstract][Full Text] [Related]
59. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein.
Snitkovsky S; Young JA
Virology; 2002 Jan; 292(1):150-5. PubMed ID: 11878917
[TBL] [Abstract][Full Text] [Related]
60. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
